Security key
46266A109
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 7,850,767
- Total 13F value
- $750,167,626
- Share change
- +216,820
- Put/Call ratio
- 122%
- SEC-reported price per share
- $95.56
- Number of holders
- 213
- Value change
- +$20,485,547
- Number of buys
- 113
- Number of sells
- 90
- Shares outstanding
- 12,796,966
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
213
Top holders
10
IRMD full security history
Ownership snapshot
Full 13F holder table
IRADIMED CORP SEC filings
IRADIMED CORP company facts
Broader feeds
Ownership snapshot
Top reported holders of IRMD - IRADIMED CORP - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Roger E. Susi
Disclosed value leader
Roger E. Susi
Comparable rows
15/15
Latest evidence
20 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 35%
13D/G row: Roger E. Susi
Showing 1-6 of 15 holder rows.
Quick read
Roger E. Susi leads the comparable SEC ownership view at 35%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Roger E. Susi's linked filing trail.
Comparable ownership
Top 5
Roger E. Susi
35%
BlackRock, Inc.
5%
Nine Ten Capital Management LLC
3.4%
John Glenn
0.09%
RENAISSANCE TECHNOLOGIES LLC
3.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Roger E. Susi |
13D/G
3/4/5
CEO, President, Chairman, Director, 10%+ Owner
|
35%
|
$428,400,317
4,450,450 shares
|
$0 | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5%
from 13D/G
|
$93,159,199
967,787 shares
|
— | 31 Mar 2026 |
| Nine Ten Capital Management LLC |
13D/G
13F
Nine Ten Capital Management · Company
|
3.4%
|
$42,119,289
428,477 shares
|
-$46,933,237 | 31 Dec 2025 |
| John Glenn |
3/4/5
CFO
|
0.09%
|
$4,596,346
11,937 shares
mixed-class rows
|
-$2,359,503 | 20 Jun 2026 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
3.4%
|
$42,422,937
440,712 shares
|
— | 31 Mar 2026 |
| Copeland Capital Management, LLC |
13F
Company
|
2.8%
|
$34,588,697
359,325 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
213
Shares
7,850,767
Rows available
213
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
228
Q2 2026 holders
213
Holder diff
-15
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|